| Effects of p38 MAPK Inhibitor POLB 001 on in Vivo LPS Challenge Responses (NCT05765955) | Poolbeg Pharma plc | 2022-07-22 |
| A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine in Adults Primed With H5N1 Influenza Vaccine or Unprimed (NCT05422326) | Seqirus | 2022-07-18 |
| A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza (NCT05702489) | Nanjing Zenshine Pharmaceuticals | 2022-07-17 |
| Efficacy and Safety of XC8, Film-coated Tablets, 40 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection (NCT05273619) | Valenta Pharm JSC | 2022-05-23 |
| A Study To Learn About The Study Vaccine (Called Self-Amplifying Ribonucleic Acid (RNA)) For The Prevention of Influenza (NCT05227001) | Pfizer | 2022-04-28 |
| Clinical Trial of Quadrivalent Influenza Virus Split Vaccine in Population Aged 3-8 Years (NCT05138705) | Shanghai Institute Of Biological Products | 2021-12-14 |
| Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults (NCT05108818) | University of Pennsylvania | 2021-10-07 |
| A Clinical Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Quadrivalent Influenza Vaccine Compared With a Licensed Quadrivalent Vaccine in Adults 50 to 64 Years of Age (NCT05044195) | Seqirus | 2021-09-30 |
| Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections (NCT05269290) | Valenta Pharm JSC | 2021-09-23 |
| A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza (NCT05052697) | Pfizer | 2021-09-13 |
| Baloxavir Versus Oseltamivir for Nursing Home Influenza Outbreaks (NCT05012189) | Insight Therapeutics, LLC | 2021-08-06 |
| Universal Anti-Viral Vaccine for Healthy Elderly Adults (NCT04441047) | Mirror Biologics, Inc. | 2021-07-12 |
| Safety and Immunogenicity of the Butantan Quadrivalent Influenza Vaccine (NCT03927131) | Butantan Institute | 2021-05-12 |
| Evaluation of Immunogenicity and Safety of Combined Immunization of COVAX (Produced in Wuhan) and PPV23 / IIV4 (NCT05079152) | China National Biotec Group Company Limited | 2021-05-06 |
| Efficacy and Safety of XC8, Film-coated Tablets, 10 mg in Patients With Dry Non-productive Cough Against Acute Respiratory Viral Infection (NCT05269329) | Valenta Pharm JSC | 2021-04-26 |
| A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older (NCT04789577) | GlaxoSmithKline | 2021-03-16 |
| Evaluation of Immunogenicity and Safety of Combined Immunization of COVID-19 Vaccine (Produced in Beijing) and PPV23 / IIV4 (NCT04790851) | China National Biotec Group Company Limited | 2021-03-10 |
| Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old (NCT05470582) | St. Petersburg Research Institute of Vaccines and Sera | 2021-02-16 |
| A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine (NCT04669691) | Seqirus | 2020-12-19 |
| Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine (NCT05869201) | St. Petersburg Research Institute of Vaccines and Sera | 2020-10-06 |
| Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (NCT04576377) | The University of Hong Kong | 2020-10-05 |
| Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates at a Large Retail Pharmacy (NCT04590066) | University of Pennsylvania | 2020-09-25 |
| Influence of Prior Infection With COVID-19 on Occurrence of Influenza-like Illness or Acute Respiratory Infection (NCT04527614) | Sciensano | 2020-09-24 |
| Testing Multiple Behavioral Science Strategies to Increase Flu-Shot Rates (NCT04565353) | University of Pennsylvania | 2020-09-20 |
| Evaluation of Humoral Immunity Following COVID-19 in Pregnancy (NCT04568044) | Imperial College London | 2020-09-16 |
| Evaluation of Safety and Immunogenicity of Combined Immunization of PPV23 and IIV4 (NCT04559204) | China National Biotec Group Company Limited | 2020-09-11 |
| Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and Protection (NCT05110911) | University of Melbourne | 2020-04-02 |
| Burden of Influenza at Emergency Department (ED) Level in European Countries (NCT04244500) | University of Rostock | 2020-01-27 |
| Trial of Tolerability, Reactogenicity, Safety and Immunogenicity of Flu-M [Inactivated Split Influenza Vaccine] in Pregnant Women (NCT05457894) | St. Petersburg Research Institute of Vaccines and Sera | 2020-01-23 |
| Persuasion in Medicine: Experimental Evidence on Sender and Signal Effects (NCT04160975) | Harvard University | 2019-12-20 |
| Prevalence of Influenza RelAted Invasive Aspergillosis (NCT04172610) | Karolinska University Hospital | 2019-12-02 |
| Functional Consequences of T-bet Expression in Flu-specific Memory B Cells After Live Attenuated Influenza Vaccine (LAIV) (NCT04080245) | University of Alabama at Birmingham | 2019-11-15 |
| Immunologic Response to FluMist vs. Flucelvax (NCT03982069) | Richard Zimmerman MD | 2019-09-20 |
| Financing Strategies of Influenza Vaccination in China (NCT04038333) | Peking University | 2019-08-01 |
| Recombinant Influenza Vaccination in U.S. Nursing Homes (NCT03965195) | Insight Therapeutics, LLC | 2019-07-20 |
| Efficacy Study With QIVc in Pediatric Subjects (NCT03932682) | Seqirus | 2019-05-13 |
| Kinetics of the Immune Response to Inactivated Influenza Vaccine in Healthy Adults (NCT03743688) | Vanderbilt University Medical Center | 2018-12-04 |
| Nudging for Vaccination : Efficacity and Acceptability Among Medical Students (NCT03768596) | Adriaan Barbaroux | 2018-11-07 |
| Resistance Exercise to Improve Flu Vaccine for Older Adults (NCT03736759) | University of Houston | 2018-10-08 |
| A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Elderly Healthy Subjects (NCT03657719) | Green Cross Corporation | 2018-10-01 |
| Herd Immunity and Influenza Vaccine Uptake (NCT03748160) | Finnish Institute for Health and Welfare | 2018-10-01 |
| Phase 2 Dose and Formulation Confirmation of Quad-NIV in Older Adults (NCT03658629) | Novavax | 2018-09-24 |
| Immunologic Response to Influenza Vaccination in Children and Adolescents (NCT03614975) | Richard Zimmerman MD | 2018-09-13 |
| Adjuvanted Influenza Vaccination Year 2 Follow-On Survey (NCT03599739) | Insight Therapeutics, LLC | 2018-07-13 |
| Active Surveillance for Adverse Events Following Immunization With the Butantan Trivalent Influenza Vaccine (2018) (NCT03392207) | Butantan Institute | 2018-04-23 |
| Evaluation of a Recombinant Quadrivalent Influenza Vaccine Versus a Marketed Quadrivalent Inactivated Influenza Vaccine in Children 3 to 17. (NCT03460743) | Laboratorios Liomont | 2018-03-22 |
| Evaluation of the Roche Liat Flu/RSV Assay for Management of Influenza in the Emergency Department (NCT02899065) | University of California, Davis | 2018-03-06 |
| A Pharmacokinetics Study of Favipiravir in Patients With Severe Influenza (NCT03394209) | Capital Medical University | 2018-02-06 |
| Evaluating The Safety And Clinical Efficacy Of Elderberry Extract In Patients With Influenza (NCT03410862) | michael macknin | 2018-01-29 |
| A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults (NCT03357263) | Green Cross Corporation | 2017-11-20 |
| Comparative Tests of Flu Vaccination Phone Messages (NCT03332992) | University of Michigan | 2017-11-11 |
| Centralized Reminder Recall - Flu RCT2 (NCT03294473) | University of California, Los Angeles | 2017-10-18 |
| Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults (NCT03314662) | Seqirus | 2017-10-17 |
| Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong (NCT03330132) | The University of Hong Kong | 2017-10-07 |
| Cardiac Injury in Patients With Influenza (NCT03339180) | Örebro University, Sweden | 2017-10-01 |
| Immunogenicity and Safety for 'IL-YANG Quadrivalent Influenza Vaccine' in Healthy Korean Children and Adolescents (NCT03445468) | Il-Yang Pharm. Co., Ltd. | 2017-09-20 |
| Panblok H7 Vaccine Adjuvanted With AS03 or MF59 (NCT03283319) | Biomedical Advanced Research and Development Authority | 2017-09-20 |
| Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines: Pilot Study in England (NCT03278067) | GlaxoSmithKline | 2017-09-12 |
| Prevalence, Strain Circulation and Disease Burden Study of Seasonal Influenza A and B in Panama, Selected Countries of Central America and the Caribbean From the Year 2010 to 2015 (NCT02885246) | GlaxoSmithKline | 2017-09-11 |
| A Study to Evaluate the Reactogenicity, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Investigational Supra-seasonal Universal Influenza Vaccines - Inactivated (SUIVs) (GSK3816302A) in Healthy Adults Aged 18 to 39 Years (NCT03275389) | GlaxoSmithKline | 2017-09-08 |
| Afluria Pregnancy Registry (NCT03442582) | Seqirus | 2017-09-08 |
| Flucelvax (TIVc or QIVc) Pregnancy Registry (NCT03438487) | Seqirus | 2017-09-01 |
| Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age (NCT03165617) | Seqirus | 2017-05-25 |
| Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S) - PHASE 2/3 (NCT03095599) | Institute of Vaccines and Medical Biologicals, Vietnam | 2017-03-20 |
| Clinical Performance of the Diassess Influenza A and B Test (NCT03035396) | Diassess Inc. | 2016-12-29 |
| Rapid Diagnostics for Upper Respiratory Infections in the Emergency Department (NCT02957136) | University of California, Davis | 2016-12-08 |
| Assessment of the Clinical Performance of the ARROW-FLU System (NCT02996136) | Sekisui Diagnostics, LLC | 2016-12-01 |
| A Study to Determine the Safety and Attack Rate of the Seasonal Flu in Healthy Volunteers (NCT04372719) | SGS Life Sciences, a division of SGS Belgium NV | 2016-11-02 |
| Rapid Assessment of and Prophylaxis for Influenza in Dwellers of Long-term Care Facilities (NCT02964871) | University of Wisconsin, Madison | 2016-11-01 |
| Evaluation of Safety of GlaxoSmithKline (GSK) Vaccines' Quadrivalent Seasonal Influenza Vaccine, Fluarix Tetra When Administered According to the Approved Prescribing Information (PI) in Korea. (NCT02663102) | GlaxoSmithKline | 2016-10-20 |
| A Study to Evaluate the Efficacy and Safety of GC3110A in Healthy Subjects Aged 65 Years and Older (NCT02917304) | Green Cross Corporation | 2016-10-10 |
| Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 Months (NCT03020628) | SK Chemicals Co., Ltd. | 2016-10-01 |
| Childhood Influenza Immunisation in General Practice Invitation Trial (NCT02921633) | Public Health England | 2016-10-01 |
| Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis (NCT02831608) | Ole Frobert, MD, PhD | 2016-10-01 |
| A Study to Evaluate Efficacy and Safety of GC3110B in Healthy Adults (NCT02915809) | Green Cross Corporation | 2016-10-01 |
| A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age. (NCT02914275) | Seqirus | 2016-09-27 |
| Post-authorisation Passive Enhanced Safety Surveillance of Seasonal Influenza Vaccines (NCT02893878) | GlaxoSmithKline | 2016-09-12 |
| Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU (NCT02998996) | Eurocine Vaccines AB | 2016-09-01 |
| A Clinical Trial of KT07 Capsule in the U.S.A (NCT02867358) | Yiling Pharmaceutical Inc. | 2016-09-01 |
| Childhood Influenza Immunisation Invitation Trial in Schools (NCT02883972) | Public Health England | 2016-09-01 |
| Specific Respiratory Infections as Triggers of Acute Medical Events (NCT02984280) | University College, London | 2016-09-01 |
| Reactogenicity, Safety and Immunogenicity Study of a Allantoic Split Inactivated Seasonal Influenza Vaccine (NCT03028116) | Research Institute for Biological Safety Problems | 2016-05-01 |
| Tropical Influenza Control Strategies for the Elderly (NCT02655874) | Tan Tock Seng Hospital | 2016-05-01 |
| A Study of a Seasonal Trivalent Split, Inactivated Influenza Vaccine (NCT02585700) | Institute of Virology, Vaccines and Sera, Torlak | 2015-11-01 |
| Idylla IFV-RSV Panel Clinical Testing (NCT02786381) | Janssen Pharmaceutica N.V., Belgium | 2015-11-01 |
| Seasonal Trivalent Inactivated Split Virion Influenza Vaccine Clinical Trial (IVACFLU-S) (NCT02598089) | Institute of Vaccines and Medical Biologicals, Vietnam | 2015-11-01 |
| Impact of Patient Education on Influenza Vaccine Uptake Among Community-dwelling Chinese Elderly (NCT02741843) | The University of Hong Kong | 2015-10-01 |
| A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age (NCT02545543) | Seqirus | 2015-09-01 |
| The Effect of Live Attenuated Inactivated Influenza Vaccine on Experimental Human Pneumococcal Carriage Study (NCT03502291) | Liverpool University Hospitals NHS Foundation Trust | 2015-08-01 |
| Pharmacokinetics of Zanamivir After Single and Repeated Dose Infusion Administration in Healthy Chinese Adults (NCT02377401) | GlaxoSmithKline | 2015-04-28 |
| Influenza Vaccine in HIV Study (NCT02632578) | University of Melbourne | 2015-02-01 |
| Study to Evaluate the Safety and Immunogenicity of 'IL-YANG Flu Vaccine Quadrivalent Inj' in Healthy Korean Adults (NCT02480998) | Il-Yang Pharm. Co., Ltd. | 2015-02-01 |
| Inactivated Influenza Via Jet Injection (NCT02290691) | PharmaJet, Inc. | 2014-11-01 |
| Promoting Influenza Vaccination In General Practice Waiting Rooms (NCT03239795) | Christophe Berkhout | 2014-10-15 |
| Mail Outreach To Increase Vaccination Acceptance Through Engagement (NCT02243774) | Brigham and Women's Hospital | 2014-09-01 |
| Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and Adolescents (NCT02621164) | SK Chemicals Co., Ltd. | 2014-09-01 |
| A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years to < 9 Years (NCT02212106) | Seqirus | 2014-09-01 |
| A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above. (NCT02214225) | Seqirus | 2014-08-01 |
| Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o. (NCT03191097) | Valenta Pharm JSC | 2014-08-01 |
| Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers (NCT02019745) | University of North Carolina, Chapel Hill | 2014-06-01 |